High-Flow oxygen may shield lungs after keyhole surgery
NCT ID NCT07676760
First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This study investigates whether high-flow nasal cannula (HFNC) oxygen therapy can reduce lung collapse (atelectasis) after laparoscopic surgery. About 90 adults undergoing elective laparoscopic procedures will receive either HFNC or standard oxygen after breathing tube removal. Doctors will use lung ultrasound to compare lung health between the two groups. The goal is to see if HFNC helps keep lungs open and lowers the risk of breathing problems after surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
High-Flow Nasal Cannula (HFNC) oxygen therapy
What this could lead to
If effective, HFNC could become a standard way to prevent lung collapse after laparoscopic surgery, reducing breathing complications.
What could go wrong
This is a small observational study, not a large trial. Results may not apply to all patients, and HFNC might not significantly reduce atelectasis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PULMONARY COMPLICATIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••